JILLIAN COLPITTS: Open Payments
NPI 1215272224 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 49 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 11 | $375 |
| Amgen Inc. | 2 | $170 |
| ABBVIE INC. | 10 | $140 |
| Novartis Pharmaceuticals Corporation | 7 | $119 |
| GENZYME CORPORATION | 4 | $76 |
| Incyte Corporation | 2 | $59 |
| Lilly USA, LLC | 3 | $49 |
| Janssen Biotech, Inc. | 2 | $41 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $39 |
| Bard Peripheral Vascular, Inc. | 1 | $30 |
Products named: NEMLUVIO, UPLIZNA, DUPIXENT, SKYRIZI, OPZELURA, EBGLYSS, RINVOQ, TREMFYA.
Industry payments across IN — which companies pay providers there.
